EX-4.1
from 8-K
8 pages
Second Supplemental Indenture Dated as of February 15, 2011 Between US Oncology, Inc., and Wilmington Trust Fsb, as Trustee to the Indenture Dated as of June 18, 2009 Among US Oncology, Inc., the Subsidiary Guarantors Named Therein and Wilmington Trust Fsb as Trustee 9.125% Senior Secured Notes Due 2017
12/34/56
EX-4.1
from 8-K
17 pages
Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), New York, New York, to the Company or Its Agent for Registration of Transfer, Exchange or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co., or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein
12/34/56
EX-4.1
from 8-K
16 pages
Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), New York, New York, to the Company or Its Agent for Registration of Transfer, Exchange or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co., or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein
12/34/56
EX-4.9
from S-4
14 pages
This First Supplemental Indenture, Dated as of August 20, 2004 (This “First Supplemental Indenture”), Is by and Among US Oncology, Inc., a Delaware Corporation (“US Oncology”), Each of the Parties Identified as a Subsidiary Guarantor on the Signature Pages Hereto (Each, a “Subsidiary Guarantor” and Collectively, the “Subsidiary Guarantors”) and Lasalle Bank National Association, a National Banking Association, as Trustee (The “Trustee”)
12/34/56
EX-4.6
from S-4
14 pages
This First Supplemental Indenture, Dated as of August 20, 2004 (This “First Supplemental Indenture”), Is by and Among US Oncology, Inc., a Delaware Corporation (“US Oncology”), Each of the Parties Identified as a Subsidiary Guarantor on the Signature Pages Hereto (Each, a “Subsidiary Guarantor” and Collectively, the “Subsidiary Guarantors”) and Lasalle Bank National Association, a National Banking Association, as Trustee (The “Trustee”)
12/34/56
